Dimensional Fund Advisors’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
FFM
APM
OCA
Dimensional Fund Advisors's DNTH Position: Q2 2026 in Review
Dimensional Fund Advisors reduced its Dianthus Therapeutics (DNTH) stake by 1.2% in Q2 2026, selling an estimated $344K and leaving 321,503 shares worth $31.3M. The position accounts for 0.01% of the portfolio, ranked #1832.
Dimensional Fund Advisors first reported a position in DNTH in Q1 2020 and has held it in 18 quarters since. 269 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.
- Dimensional Fund Advisors held 321,503 shares of Dianthus Therapeutics worth $31.3M as of Q2 2026.
- Dimensional Fund Advisors sold 3,937 Dianthus Therapeutics shares in Q2 2026, an estimated $344K.
- Dianthus Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1832 holding.
- Dimensional Fund Advisors first reported a position in Dianthus Therapeutics in Q1 2020 and has held it in 18 quarters since.
- 269 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.